Login / Signup

Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial).

Mohammad Shafi KuchayPushpender KhatanaMitali MishraParvathi SurendranParjeet KaurJasjeet Singh WasirHarmandeep Kaur GillApanshu SinghRujul JainChhavi KohliGazal BakshiVishnupriya RadhikaSumayya SaheerManish Kumar SinghSunil Kumar Mishra
Published in: Acta diabetologica (2023)
Dapagliflozin complementary to basal-bolus insulin does not improve glycemia further over and above the basal-bolus insulin alone in hospitalized cardiac surgery patients. Dapagliflozin significantly increases plasma ketones levels. Safety of dapagliflozin in hospitalized patients needs further investigation. Trial registration ClinicalTrials.gov NCT05457933.
Keyphrases